Actively Recruiting
REal-world Valued Outcomes of a noveL Balloon-in-basket pUlsed Field ablaTION Catheter for Atrial Fibrillation RegistrY
Led by Cardioangiologisches Centrum Bethanien · Updated on 2026-03-09
1000
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
describe real-world adaption, work-flow data as well as procedural and follow-up outcomes after balloon-in-basket guided PFA for AF in early European users.
CONDITIONS
Official Title
REal-world Valued Outcomes of a noveL Balloon-in-basket pUlsed Field ablaTION Catheter for Atrial Fibrillation RegistrY
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who underwent catheter ablation for atrial fibrillation using the novel balloon-in-basket VOLT PFA system
- Age 18 years or older
- Able and willing to give informed consent
You will not qualify if you...
- Left atrial diameter greater than 60 mm
- Severe mitral stenosis or regurgitation, or prior mitral valve reconstruction or replacement
- Conditions contraindicating atrial fibrillation ablation as assessed by the investigator
- Known intra-cardiac thrombus
- Contraindication for oral anticoagulation
- Untreated or uncontrolled hyperthyroidism or other reversible causes for atrial fibrillation such as alcoholism
- Pregnant or breastfeeding women or women of childbearing potential not using adequate birth control
- Active systemic infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mvz Ccb Am Agaplesion Markus Krankenhaus
Frankfurt, Germany, 60431
Actively Recruiting
Research Team
B
Boris Schmidt, Prof.Dr.med.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here